Clinical applicability of B-type natriuretic peptide in patients with suspected heart failure in primary care in Spain: the PANAMA study

References

• Senni M, Tribouilloy CM, Rodeheffer RJ et al. Congestive heart failure in the community: trends in incidence and survival in a 10-year period. Arch. Intern. Med.159, 29–34 (1999).
   PubMedGoogle Scholar
• Dickstein K, Cohen-Solal A, Filippatos G et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur. Heart J.29, 2388–2442 (2008).
   PubMed Web of Science ®Google Scholar
• McMurray JJ, Stewart S. Heart failure. Epidemiology, aetiology, and prognosis of heart failure. Heart83, 596–602 (2000).
   PubMed Web of Science ®Google Scholar
• Mant J, Doust J, Roalfe A et al. Systematic review and individual patient data meta-analysis of diagnosis of heart failure, with modelling of implications of different diagnostic strategies in primary care. Health. Technol. Assess.13, 1–207 (2009).
   PubMed Web of Science ®Google Scholar
• Barrios V, Escobar C, De La Sierra A, Llisterri JL, González-Segura D. Detection of unrecognized clinical heart failure in elderly hypertensive women attended in primary care setting. Blood Press.19, 301–307 (2010).
   PubMed Web of Science ®Google Scholar
• Kelder JC, Rutten FH, Hoes AW. Clinically relevant diagnostic research in primary care: the example of B-type natriuretic peptides in the detection of heart failure. Fam. Pract.26, 69–74 (2009).
   PubMed Web of Science ®Google Scholar
• Barrios V, Calderón A, Escobar C et al. Electrocardiographic left ventricular hypertrophy regression induced by an angiotensin receptor blocker-based regimen in daily clinical practice: the SARA study. J. Hypertens.25, 1967–1973 (2007).
   PubMed Web of Science ®Google Scholar
• Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N. Engl. J. Med.339, 321–328 (1998).
   PubMed Web of Science ®Google Scholar
• Rutten FH, Cramer MJ, Zuithoff NP et al. Comparison of B-type natriuretic peptide assays for identifying heart failure in stable elderly patients with a clinical diagnosis of chronic obstructive pulmonary disease. Eur. J. Heart. Fail.9, 651–659 (2007).
   PubMed Web of Science ®Google Scholar
• Battaglia M, Pewsner D, Juni P, Egger M, Bucher HC, Bachmann LM. Accuracy of B-type natriuretic peptide tests to exclude congestive heart failure: systematic review of test accuracy studies. Arch. Intern. Med.166, 1073–1080 (2006).
   PubMed Web of Science ®Google Scholar
• Maisel A, Mueller C, Adams K Jr et al. State of the art: using natriuretic peptide levels in clinical practice. Eur. J. Heart Fail.10, 824–839 (2008).
   PubMed Web of Science ®Google Scholar
• McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham study. N. Engl. J. Med.285, 1441–1446 (1971).
   PubMed Web of Science ®Google Scholar
• Mancia G, De Backer G, Dominiczak A et al. 2007 guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J. Hypertens.25, 1105–1187 (2007).
   PubMed Web of Science ®Google Scholar
• van Heur LM, Baur LH, Tent M et al. Evaluation of an open-access echocardiography service in the Netherlands: a mixed methods study of indications, outcomes, patient management and trends. BMC. Health. Serv. Res.10, 37 (2010).
   PubMed Web of Science ®Google Scholar
• Di Angelantonio E, Chowdhury R, Sarwar N et al. B-type natriuretic peptides and cardiovascular risk: systematic review and meta-analysis of 40 prospective studies. Circulation120, 2177–2187 (2009).
   PubMed Web of Science ®Google Scholar
• Barrios V, Escobar C, Calderón A, Echarri R, González-Pedel V, Ruilope LM; CONTROLRISK Investigators. Cardiovascular risk profile and risk stratification of the hypertensive population attended by general practitioners and specialists in Spain. The CONTROLRISK study. J. Hum. Hypertens.21, 479–485 (2007).
   PubMed Web of Science ®Google Scholar
• Betti I, Castelli G, Barchielli A et al. The role of N-terminal PRO-brain natriuretic peptide and echocardiography for screening asymptomatic left ventricular dysfunction in a population at high risk for heart failure. The PROBE-HF study. J. Card. Fail.15, 377–384 (2009).
   PubMed Web of Science ®Google Scholar
• Zuber M, Cuculi F, Attenhofer Jost CH et al. Value of brain natriuretic peptides in primary care patients with the clinical diagnosis of chronic heart failure. Scand. Cardiovasc. J.43, 324–329 (2009).
   PubMed Web of Science ®Google Scholar
• Gustafsson F, Steensgaard-Hansen F, Badskjaer J, Poulsen AH, Corell P, Hildebrandt P. Diagnostic and prognostic performance of N-terminal proBNP in primary care patients with suspected heart failure. J. Card. Fail.11(Suppl. 5), S15–S20 (2005).
   PubMed Web of Science ®Google Scholar
• Olofsson M, Boman K. Usefulness of natriuretic peptides in primary health care: an exploratory study in elderly patients. Scand. J. Prim. Health Care28, 29–35 (2010).
   PubMed Web of Science ®Google Scholar
• Fuat A, Murphy JJ, Hungin AP et al. The diagnostic accuracy and utility of a B-type natriuretic peptide test in a community population of patients with suspected heart failure. Br. J. Gen. Pract.56, 327–333 (2006).
   PubMed Web of Science ®Google Scholar
• Reinhold T, Berghöfer A, Willich SN. Is the determination of biomarkers worth its price? Review of the literature taking brain natriuretic peptides (BNP) as an example. Herz35, 1–10 (2010).
   PubMed Web of Science ®Google Scholar
• Bolt CL, Baur L, Stoffers J, Lenderink T, Winkens R. Novel strategies for the detection of systolic and diastolic heart failure. Curr. Cardiol. Rev.5, 112–118 (2009).
   PubMedGoogle Scholar